| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Revenue | 1,173 | 564 | 887 | |
| Cost of sales | 400 | 319 | 469 | |
| Gross profit | 773 | 245 | 418 | |
| Research and development | 428 | 503 | 657 | |
| Sales and marketing | 1,538 | 1,119 | 1,212 | |
| General and administrative | 2,199 | 1,480 | 1,764 | |
| Total operating expenses | 4,165 | 3,102 | 3,633 | |
| Loss from operations | -3,392 | -2,857 | -3,215 | |
| Other income (expense), net | - | 0 | - | |
| Interest expense | - | 0 | - | |
| Gain on investments | 53 | 88 | 31 | |
| Total other income, net | 53 | 88 | 31 | |
| Net loss | -3,339 | -2,769 | -3,184 | |
| Foreign currency translation adjustment | - | 0 | - | |
| Total comprehensive loss | -3,339 | -2,769 | -3,184 | |
| Basic (in dollars per share) | -0.4 | -0.36 | -3.63 | |
| Basic (in shares) | 8,250 | 7,591 | 877 | |
| Diluted (in dollars per share) | -0.4 | -0.36 | -3.63 | |
| Diluted (in shares) | 8,250 | 7,591 | 877 | |
Tenon Medical, Inc. (TNON)
Tenon Medical, Inc. (TNON)